#oncology #Vienna #Austria #RaySearch #ESTRO 2025

RaySearch Presents Future-Forward Oncology Innovations at ESTRO 2025

RaySearch Laboratories AB (publ) is excited to announce its participation in the esteemed ESTRO (European Society for Radiotherapy and Oncology) congress, set to take place in Vienna, Austria, from May 3 to 5, 2025. This year's congress theme centers around groundbreaking technological advancements that are poised to reshape the landscape of cancer treatment. Under the banner of the global campaign, "Coding Energy to End Cancer," RaySearch will exhibit its latest innovations, prominently featuring the treatment planning system RayStation®, the oncology information system RayCare®, and the cloud-based analytics platform RayIntelligence®.

Innovative Solutions for Enhanced Patient Care

During ESTRO 2025, attendees will have the opportunity to engage with RaySearch’s experts and experience live demonstrations of how these state-of-the-art tools can revolutionize oncology workflows and improve patient care. Visitors can book their demonstrations at booth #800, where they will explore features designed to propel the profession into the future of cancer therapy.

Key Focus Areas:

RaySearch will spotlight five pivotal areas that are critical to advancing the future of oncology care:

1. Adaptive Radiotherapy: Empowering clinicians to tailor treatment plans to individuals based on their unique needs.
2. Automated Workflows: Streamlining complicated workflows to maximize efficiency and enhance treatment quality, allowing physicians to focus more on patient care.
3. Integrated Planning: Creating a cohesive system among different platforms to provide seamless treatment planning without data loss.
4. Analyzing Clinical Data: Transforming disjointed clinical information into concrete, actionable insights that can guide treatment decisions.
5. Uniting Industry: Fostering open collaboration across different vendors to expand innovation and options.

Collaborative Solutions with Industry Partners
At this event, RaySearch will also showcase collaborative solutions created in conjunction with other leading industry players including IBA, Vision RT, BEBIG Medical, GE Healthcare, Mevion Medical Systems, and Leo Cancer Care. This partnership effort is designed to enhance the offerings available to clinicians worldwide.

Feature Highlights at the RaySearch Booth

Among the innovations on display, RaySearch will highlight the new features of RayStation, which include:

• - High-speed adaptive replanning capabilities
• - Upright treatment planning
• - Advanced AI-driven image segmentation
• - Enhanced automation through machine learning alongside traditional techniques

In addition, RayStation will introduce three new models designed for deep learning planning — a unique aspect of our offering. The upgraded algorithm, ECHO, originally developed at Memorial Sloan Kettering Cancer Center, represents a significant leap forward in automated planning capability.

Along with RayStation, RayCare’s transformative approach will be demonstrated, showing how it connects and orchestrates each phase of the cancer treatment process, integrating workflows and ensuring a patient-centered experience.

RayIntelligence: Data-Driven Insights

RayIntelligence, a novel cloud-based analytics solution, will also be a focal point. It effortlessly integrates with RayStation and RayCare, compiling fragmented data into insightful dashboards that illuminate clinical operations and performance metrics. Visitors can explore the treatment planning and clinic overview dashboards while gaining insights from external data sources.

Moreover, RaySearch will introduce enhancements in ablation support and quality control procedures for chemotherapy, supplemented by the introduction of RayCommand®, a treatment control system linking planning and treatment execution.

The Vision of RaySearch

Johan Löf, the founder and CEO of RaySearch, expressed his enthusiasm about the company's vision saying, "The development of advanced automated solutions and optimized workflows is essential in helping clinicians provide personalized treatment options to patients. At ESTRO 2025, we are excited to engage with both current and prospective clients and showcase how our latest innovations can bring that vision to life."

To delve deeper into the narrative behind the campaign, "Coding Energy to End Cancer," and discover all that RaySearch has to offer at ESTRO 2025, visit their official site at raysearchlabs.com. For more information, interested parties can contact Johan Löf directly via phone or at the provided email.

This information serves as an example of how technology and collaboration in the healthcare field can lead to a future where more personalized and effective treatment possibilities exist for cancer patients.